Skip to main content
Thursday
December 05, 2024
Sign In
Subscribe
Home
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
Podcast
World+Biz
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Tech
Magazine
Climate Change
Health
Cartoons
বাংলা
THURSDAY,
DECEMBER 05, 2024
AstraZeneca
Coronavirus chronicle
Sri Lanka reports six cases of blood clots among AstraZeneca vaccine recipients, 3 dead
Coronavirus chronicle
India's Serum institute to sell AstraZeneca vaccine to private hospitals at $8/dose
Panorama
The real vaccine crisis isn’t about J&J or AstraZeneca
Coronavirus chronicle
'I Don't Want That' - France Struggles to Pitch AstraZeneca Vaccine
Coronavirus chronicle
Canada has second case of rare blood clots after AstraZeneca Covid immunization
Coronavirus chronicle
J&J scientists refute idea that Covid-19 vaccine's design linked to clots
Coronavirus chronicle
Australia reports first blood clot death 'likely' linked to AstraZeneca vaccine
Coronavirus chronicle
EU Commission to end AstraZeneca and J&J vaccine contracts at expiry
Coronavirus chronicle
Australia abandons Covid-19 vaccination targets after new advice on AstraZeneca shots
Coronavirus chronicle
Philippines suspends use of AstraZeneca vaccine for people under 60
Coronavirus chronicle
Spain limits AstraZeneca coronavirus vaccine to over 60-year olds
Coronavirus chronicle
Australia to continue AstraZeneca vaccine rollout, review EU findings
Coronavirus chronicle
EU drug regulator: 169 cases of rare brain blood clot identified as of 4 April
Show More